Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Saturday, June 1, 2013
USP Key Issue: Standards for Veterinary Drugs May 31, 2013
Consistent with its commitment to provide public standards for the quality, consistency, purity, identity, and strength of all medicines, USP is advancing its standards for drugs for veterinary use. These standards include monographs and general chapters (including those devoted to veterinary drug topics) applicable to any articles recognized in the United States Pharmacopeia–National Formulary (USP–NF), whether in the form of a manufactured or a compounded preparation. USP has been active in setting standards for veterinary drugs for many years, and recently has expanded itsmission statementto acknowledge this.
Solubility Criteria for Veterinary Drugs
A summary of the discussions during the Workshop on Solubility Criteria for Veterinary Productsthat took place at USP headquarters in Rockville, MD on November 7–8, 2012 will be published in Pharmacopeial Forum 39(4), together with Stimuli articles that will provide explanations for the approaches to be included in a new USP General Chapter <1236>, provisionally titled Determination of Thermodynamic Solubility of Active
On November 9, 2012, USP held its firstVeterinary Drugs Stakeholder Forum, which provided an opportunity to educate stakeholders on USP activities, help USP staff understand veterinary drug issues, and discuss compendial issues and emerging USP initiatives that may affect veterinary drug stakeholders. USP anticipates holding asecond Veterinary Drugs Stakeholder Forumon November 20–21, 2013.